EP 125: Structural Interventions and Emerging Pharmacotherapies: The Year 2024 In Review with Dr Sukh Nijjer
EP 125: Structural Interventions and Emerging Pharmacotherapies: The Year 2024 In Review with Dr Sukh Nijjer

Average (ratings)
No ratings
 
  Your rating

In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2024.

Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.

This episode explores emerging trends in the treatment of valvular heart disease, focussing on TAVI procedures and transcatheter interventions. It also covers recent advancements in pharmacological management for cardiovascular conditions. Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year’s most impactful trials:

EARLY TAVR
RESHAPE 2
MATTERHORN
TRILUMINATE
TOPSPIN
FINEARTS-HF

What are the most impactful cardiovascular trials of 2024? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?


Read MoreRead Less
Share
Up Next
Ep 126: Cardiology at a Crossroads: Building Resilient Practice Models
EP126 • Jan 27, 2025 • 41m 34s
The COVID-19 pandemic forced cardiology practices to rapidly evolve - but which changes are here to stay?

Join Dr Ankur Kalra in conversation with Dr Edward Fry, former President of the American College of Cardiology, as they explore how the pandemic catalyzed lasting changes in cardiovascular care delivery.
Read More
All Episodes
Ep 156: Gravity, the Heart, and POTS: Space Cardiology's Discoveries
EP156 • Mar 30, 2026 • 39m 47s
In this fascinating episode of Parallax, Dr Ankur Kalra is joined by Dr Benjamin Levine, Director of the Institute for Exercise and Environmental Medicine and a pioneering figure in the field of space cardiology. Together, they explore the remarkable cardiovascular adaptations that occur in microgravity, and what they are teaching clinicians about treating patients on Earth.
Read More
Ep 155: Making Every Procedure Safer, Every Patient Count: Bleeding Risk, Sex Differences, and the Future of Structural Heart
EP155 • Mar 16, 2026 • 54m 6s
In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran and Professor Nicholas Van Mieghem. The conversation spans the evolution of online medical education, sex-specific differences in cardiovascular disease, and the challenge of translating clinical evidence into everyday practice.
Read More
Ep 154: Climate Change and CV Health: From Heat Waves to Heart Risk
EP154 • Mar 02, 2026 • 29m 37s
In this episode of Parallax, Dr Ankur Kalra speaks with Dr Sameed Khatana, Assistant Professor of Medicine at the University of Pennsylvania and clinical cardiologist at the Philadelphia VA Medical Center. Their conversation examines the growing connection between environmental factors and cardiovascular health.
Read More
Ep 153: The 60-Minute Window: Solutions for Faster STEMI Diagnosis
EP153 • Feb 17, 2026 • 36m 31s
In this episode of Parallax, Dr Ankur Kalra welcomes Dr Rakesh Shah, a former interventional cardiologist, Oxford MBA graduate, and founder of DRS.LINQ.
Read More
Ep 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine
EP152 • Feb 02, 2026 • 38m 33s
In this key episode of Parallax, Dr Ankur Kalra sits down with Prof Naveed Sattar to explore how recent therapeutic breakthroughs are fundamentally reshaping the cardiologist's approach to diabetes management.
Read More
Ep 151: Cardiology's 2025 Year in Review with Dr Sukh Nijjer
EP151 • Jan 16, 2026 • 1h 40m 44s
In this highly anticipated annual year-end episode of Parallax, Dr Ankur Kalra welcomes back Dr Sukh Nijjer, an interventional cardiologist in London, for their seventh consecutive year reviewing cardiology's most significant developments.
Read More
Ep 150: Building a Legacy in Cardiology: From the NIH to JAMA Cardiology with Robert Bonow
EP150 • Jan 05, 2026 • 50m 44s
In this landmark 150th episode of Parallax marking the start of Season 8, Dr Ankur Kalra welcomes Professor Robert Bonow, Professor of Medicine and Cardiology at Northwestern University and Editor-in-Chief of JAMA Cardiology. This milestone conversation explores the career of one of cardiology's most influential academic leaders and examines how strategic vision, mentorship, and institutional leadership have shaped modern cardiovascular medicine.
Read More
Ep 149: The Placebo-Controlled Revolution: Redefining Evidence in Device Trials
EP149 • Dec 19, 2025 • 33m 7s
In this week's episode of Parallax, Dr Ankur Kalra welcomes Prof Rasha Al-Lamee, interventional cardiology consultant and professor of medicine/cardiology at Imperial College London, and deputy editor of JACC. Prof Al-Lamee has transformed interventional cardiology through her pioneering work on the ORBITA trial series and coronary sinus reducer device studies, introducing the paradigm-shifting concept of sham-controlled device trials to the field.
Read More
Ep 148: Breaking Down Healthcare Borders: Five Pillars to Revolutionary Access
EP148 • Dec 08, 2025 • 32m 30s
In this episode of Parallax, Dr Ankur Kalra welcomes Dr Sarah Matt, Associate Clinical Professor at Upstate Medical University, health tech strategist, and author of the newly released The Borderless Healthcare Revolution.
Read More
Ep 147: From Landfill to Life-Saving: GOMED's Mission to Reimagine Medical Device Distribution
EP147 • Nov 24, 2025 • 38m 44s
In this week's episode of Parallax, Dr Ankur Kalra welcomes Dr Courtney Maxey-Jones, Director of the Coronary Care Unit at Upstate University Hospital and a cardiac anesthesiologist intensivist by training. Dr Maxey-Jones co-founded and serves as Chief Operations Officer of GOMED, a not-for-profit organization transforming how we think about medical device waste and global healthcare equity.
Read More
Ep 156: Gravity, the Heart, and POTS: Space Cardiology's Discoveries
EP156 • Mar 30, 2026 • 39m 47s
In this fascinating episode of Parallax, Dr Ankur Kalra is joined by Dr Benjamin Levine, Director of the Institute for Exercise and Environmental Medicine and a pioneering figure in the field of space cardiology. Together, they explore the remarkable cardiovascular adaptations that occur in microgravity, and what they are teaching clinicians about treating patients on Earth.
Read More
Ep 155: Making Every Procedure Safer, Every Patient Count: Bleeding Risk, Sex Differences, and the Future of Structural Heart
EP155 • Mar 16, 2026 • 54m 6s
In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran and Professor Nicholas Van Mieghem. The conversation spans the evolution of online medical education, sex-specific differences in cardiovascular disease, and the challenge of translating clinical evidence into everyday practice.
Read More
Ep 154: Climate Change and CV Health: From Heat Waves to Heart Risk
EP154 • Mar 02, 2026 • 29m 37s
In this episode of Parallax, Dr Ankur Kalra speaks with Dr Sameed Khatana, Assistant Professor of Medicine at the University of Pennsylvania and clinical cardiologist at the Philadelphia VA Medical Center. Their conversation examines the growing connection between environmental factors and cardiovascular health.
Read More
Ep 153: The 60-Minute Window: Solutions for Faster STEMI Diagnosis
EP153 • Feb 17, 2026 • 36m 31s
In this episode of Parallax, Dr Ankur Kalra welcomes Dr Rakesh Shah, a former interventional cardiologist, Oxford MBA graduate, and founder of DRS.LINQ.
Read More
Ep 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine
EP152 • Feb 02, 2026 • 38m 33s
In this key episode of Parallax, Dr Ankur Kalra sits down with Prof Naveed Sattar to explore how recent therapeutic breakthroughs are fundamentally reshaping the cardiologist's approach to diabetes management.
Read More